CKD Markers Linked to Cognitive Risk
In adults with chronic kidney disease, higher proteinuria and lower estimated glomerular filtration rate are associated with increased risk of incident cognitive impairment.
By
Kathryn Wighton
February 17, 2026
Clinical Scorecard: CKD Markers Linked to Cognitive Risk
At a Glance
Category Detail
Condition Chronic Kidney Disease (CKD) and Cognitive Impairment Key Mechanisms Reduced eGFR and elevated UPCR are associated with increased cognitive impairment risk. Target Population Adults with chronic kidney disease (CKD) Care Setting Outpatient and longitudinal follow-up
Key Highlights
38% higher risk of global cognitive impairment with eGFR decline and UPCR ≥ 150 mg/g. Each 1-standard deviation increase in UPCR linked to 21% greater likelihood of impaired attention. Joint modeling shows complementary associations between eGFR decline and UPCR. Cognitive outcomes assessed using validated tests like the Modified Mini-Mental State Examination. Limitations include potential misclassification of UPCR and exclusion of end-stage CKD patients. Guideline-Based Recommendations
Diagnosis
Evaluate kidney function using eGFR and UPCR. Exclude patients with cognitive impairment at baseline from longitudinal analyses. Management
Monitor CKD severity as a risk factor for cognitive decline. Consider cognitive assessments in CKD management plans. Monitoring & Follow-up
Regular cognitive assessments for CKD patients. Track changes in eGFR and UPCR over time. Risks
Increased likelihood of cognitive impairment with declining kidney function. Potential biases from differential loss to follow-up. Patient & Prescribing Data
Adults with chronic kidney disease (CKD) enrolled in the CRIC Study.
Focus on managing CKD to mitigate cognitive decline risks.
Clinical Best Practices
Utilize race-neutral equations for eGFR calculation. Incorporate cognitive testing in routine CKD evaluations. Adjust for demographic and clinical variables in cognitive assessments. References
